EP3307876
MODIFIED NK-92 CELLS FOR TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.6.2016EP published:
13.9.2023EP application number:
16808427.5
EPO information:
European Patent Register
Max expiry date:
9.6.2036
Title in English:
MODIFIED NK-92 CELLS FOR TREATING CANCERLanguage of the patent:
English
Timeline
Today
10.6.2016EP application
13.9.2023EP Publication
Owner
Name:
ImmunityBio, Inc.Address:
9920 Jefferson Boulevard, Culver City, CA 90232, US
Inventor
Name:
LEE, TienAddress:
Culver City, California 90232, US
Priority
Number:
201562173701 PDate:
10.6.2015Country:
US
Number:
201662337044 PDate:
16.5.2016Country:
US
Classification
Categories:
C12N 5/0783, C07K 14/54, C07K 14/725, C07K 14/735, C07K 16/28, A61K 35/17, A61K 39/00, A61K 39/395